Clinical Trial

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The first technology is called high dose rate brachytherapy. Brachytherapy is sometimes called internal radiation therapy. High dose rate brachytherapy is a procedure that involves temporarily placing radioactive material inside the patient's body for about 10-20 minutes. Then, the remainder of the radiation treatment will be given over a 3 week period using stereotactic body radiation therapy (SBRT). SBRT is a novel treatment modality that involves the delivery of very high individual doses of radiation to tumors with high precision. This allows the doctor to deliver the same amount of radiation in a much shorter time. The purpose of this study is to determine the safety of brachytherapy when combined with hypofractionated SBRT.
Protocol Amendment History 22 amendments
This ClinicalTrials.gov record has been amended 22 times since 2012-07-31; most recent amendment 2025-09-04.
Status change: Recruiting → Active, Not Recruiting 2017-10-25
Status change: Not Yet Recruiting → Recruiting 2012-10-05
Trial Details
NCT Number NCT01655836
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Conditions Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer
Enrollment 42 participants
Start Date 2012-10-04
Primary Completion 2016-07-27 (estimated)
Study Completion 2040-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-11